Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use REYATAZ safely and effectively. See full prescribing information for REYATAZ. REYATAZ® (atazanavir) capsules, for oral useInitial U.S. Approval: 2003
Medication labelWhy this: Advisory · dailymed-prescription
REYATAZ® (atazanavir) is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection for patients 3 months and older weighing at least 5 kg. Limitations of Use: •REYATAZ is not recommended for use in pediatric patients below the age of 3 months due to the risk of kernicterus. •Use of REYATAZ/ritonavir in treatment-experienced patients should be guided by the number of baseline primary protease inhibitor resistance substitutions [see Microbiology (12.4)].
- generic_name
- atazanavir
- product_names
- ATAZANAVIR
- ndc
- 69189-3624, 0003-3624, 69189-3624-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en